Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 12, 2008, Pages 1131-1136

  Hennessy, Sean ^a,c   Leonard, Charles E ^a   Palumbo, Cristin M ^a   Bilker, Warren B ^a   Newcomb, Craig ^a   Kimmel, Stephen E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE   (United States)

Author keywords

Data collection; Database; General practice research database; Pharmacoepidemiology; Questionnaire; Validation study

Indexed keywords

CISAPRIDE; DOMPERIDONE; METOCLOPRAMIDE;

ARTICLE; CLINICAL EFFECTIVENESS; DATA BASE; DATA COLLECTION METHOD; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; GENERAL PRACTICE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION; HUMAN; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT CARE; PATIENT CODING; PATIENT IDENTIFICATION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SUDDEN DEATH; VALIDATION STUDY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DRUG TOXICITY; FACTUAL DATABASE; HEART ARRHYTHMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORD; PREDICTION AND FORECASTING; STANDARD; STATISTICS;

ARRHYTHMIAS, CARDIAC; CISAPRIDE; COHORT STUDIES; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; DOMPERIDONE; DRUG TOXICITY; FAMILY PRACTICE; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORDS; METOCLOPRAMIDE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES;

EID: 59649084983     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1632     Document Type: Article

References (14)

1. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 2005; 165: 1363-1369.
2. Centers for Disease Control and Prevention (CDC). State-specific mortality from sudden cardiac death - United States, 1999. MMWR Morb Mortal Wkly Rep 2002; 51: 123-126.
3. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moye L. Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994; 73: 346-352.
4. Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325: 1070.
5. Enger C, Cali C, Walker AM. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf 2002; 11: 477-486.
6. Walker AM, Szneke P, Weatherby LB, et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999; 107: 356-362.
7. Layton D, Key C, Shakir SA. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future. Pharmacoepidemiol Drug Saf 2003; 12: 31-40.
8. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Database. In Pharmacoepidemiology, 4th edn, Strom BL (ed). John Wiley and Sons, Inc.: Chichester, UK, 2005; 337-346.
9. Hennessy S, Bilker WB, Knauss JS, et al. Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. Br J Clin Pharmacol 2004; 58: 81-87.
10. de Abajo FJ, Garcia Rodriguez LA. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br J Clin Pharmacol 1999; 47: 307-313.
11. Garcia Rodriguez LA, Perez Gutthan S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-425.
12. National Statistics. Key health statistics from general practice 1998: analyses of morbidity and treatment data, including time trends, England and Wales. 2, 2-175. 2000. London, National Statistics. MB6.
13. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161-1167.
14. West SL, Strom BL, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In Pharmacoepidemiology. 4th edn, Strom BL (ed). John Wiley: Chichester, 2005: 709-766.